|
Confirmed Speakers:
Dimitry Samarsky, Vice President, RXI Pharmaceuticals
Annick Harel-Belan, Director, Laboratory of Epigenetics and Cancer, Institute Andre Lwoff
Tamas Dalmay, Professor, University of East Anglia
Thomas Thum, Professor, University of Wurzburg
Pal Saterom, Professor, Norwegian University of Science and Technology
Sven Diederichs, Research Fellow, Harvard Medical School
Andy Miller, Professor, Imperial College London
Minoo Rassoulzadegan, Professor, University of Nice
Gunther Hartmann, Professor, University of Bonn
Mirco Castoldi, PhD, University of Heidelberg
Ben Berkhout, Professor, University of Amsterdam
Zicai Liang, Professor, Peking University
Mark Behlke, Chief Scientific Officer, Integrated DNA
Enal Razvi, Biotechnology Analyst, Select Biosciences
Martin Kreutz, Scientist R&D - miRNA Research, Qiagen
Trevor Collingwood, Sigma Aldrich
Sonja Vorwerk, R&D Scientist, Febit
Glen Reid, Head of RNAi Product Development, Genesis Research & Development Corporation Limited
Kevin Fettes, Process Development Group Leader, Avecia Biotechnology
Nadia Normand, Bioassay Manager, Tebu-Bio
Susan Magdelano, Sr. Manager, Scientist RNAi Technologies, Applied Biosystems
Eli Hefner, PhD, Bio-Rad
Karel Fostier, PhD Student, Vrije Universiteit Brussel
Cynthia Sharma, Max Planck Institute |